Literature DB >> 26708215

Protein phosphatase 2A plays an important role in migration of bone marrow stroma cells.

Weiqian Chen1, Shizhen Wang1, Jun Xia1, Zan Huang2, Xin Tu3, Zhenya Shen4.   

Abstract

Administration of bone marrow stroma cells (BMSCs) has the potential to ameliorate degenerative disorders and to repair injured sites. The homing of transplanted BMSCs to damaged tissues is a critical property of engraftment. Therefore, it is important to understand signal molecules controlling migration of BMSCs. Here, we demonstrate that serine-threonine protein phosphatase 2A (PP2A) is responsive to migration of BMSCs. Pharmacological Inhibition of PP2A, using okadaic acid (OA), leads to attenuated cell migration in rat primary BMSCs both in the absence or presence of stromal cell-derived factor-1 (SDF-1). Consistent with the above findings, knockdown of the main catalytic subunit PP2Acα using small interfering RNA also attenuates chemotaxis of BMSCs. On the other hand, cell viability of BMSCs remains unchanged with OA treatment or knockdown of PP2Acα subunit. Moreover, we observed an upregulation of PP2A-B55β in transcription level after SDF-1 treatment, indicating their potential role as the functioning regulatory subunit of PP2A phosphatase in BMSCs migration model. Collectively, these data provide first insight into the modulation of BMSCs migration by PP2A phosphatase activity and lay a foundation for exploring PP2A signaling as a modulating target for BMSCs transplantation.

Entities:  

Keywords:  Bone marrow stroma cells; Cell migration; Protein phosphatase 2A; Stromal cell-derived factor-1

Mesh:

Substances:

Year:  2015        PMID: 26708215     DOI: 10.1007/s11010-015-2624-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  43 in total

Review 1.  Protein phosphatase 2A: the Trojan Horse of cellular signaling.

Authors:  E Sontag
Journal:  Cell Signal       Date:  2001-01       Impact factor: 4.315

2.  A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation.

Authors:  A Ito; T R Kataoka; M Watanabe; K Nishiyama; Y Mazaki; H Sabe; Y Kitamura; H Nojima
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

3.  microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells.

Authors:  Mingning Qiu; Lei Liu; Lieqian Chen; Guobin Tan; Ziji Liang; Kangning Wang; Jianjun Liu; Hege Chen
Journal:  Biochem Biophys Res Commun       Date:  2014-08-22       Impact factor: 3.575

Review 4.  Myocardial regeneration with bone-marrow-derived stem cells.

Authors:  Young-Sup Yoon; Namho Lee; Heather Scadova
Journal:  Biol Cell       Date:  2005-04       Impact factor: 4.458

5.  Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.

Authors:  Y Khew-Goodall; R E Mayer; F Maurer; S R Stone; B A Hemmings
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

6.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Tissue-specific expression of mRNAs encoding alpha- and beta-catalytic subunits of protein phosphatase 2A.

Authors:  Y Khew-Goodall; B A Hemmings
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

8.  Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus.

Authors:  José C Crispín; Sokratis A Apostolidis; Melissa I Finnell; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

9.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Authors:  Angela Kortesidis; Andrew Zannettino; Sandra Isenmann; Songtao Shi; Tsvee Lapidot; Stan Gronthos
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

10.  Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model.

Authors:  Jigang He; Xiaomei Teng; Yunsheng Yu; Haoyue Huang; Wenxue Ye; Yinglong Ding; Zhenya Shen
Journal:  Differentiation       Date:  2013-08-25       Impact factor: 3.880

View more
  3 in total

1.  MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.

Authors:  Yueqiu Chen; Yunfeng Zhao; Weiqian Chen; Lincen Xie; Zhen-Ao Zhao; Junjie Yang; Yihuan Chen; Wei Lei; Zhenya Shen
Journal:  Stem Cell Res Ther       Date:  2017-11-25       Impact factor: 6.832

2.  Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.

Authors:  Han Shen; Guanghao Cui; Yanqiong Li; Wenxue Ye; Yimin Sun; Zihan Zhang; Jingjing Li; Guiying Xu; Xiansheng Zeng; Yanxia Zhang; Wencheng Zhang; Zan Huang; Weiqian Chen; Zhenya Shen
Journal:  Stem Cell Res Ther       Date:  2019-01-11       Impact factor: 6.832

3.  Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice.

Authors:  Pei Zhao; Wenjing Zhou; Yanxia Zhang; Jingjing Li; Ye Zhao; Lihua Pan; Zhenya Shen; Weiqian Chen; Jie Hui
Journal:  J Cell Mol Med       Date:  2020-01-13       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.